Survival after stage IA endometrial cancer; Can follow-up be altered? A prospective nationwide Danish survey

Acta Obstetricia et Gynecologica Scandinavica

Volumn 91, Issue 8, 2012, Pages 976-982

  Lajer, Henrik ^a   Elnegaard, Sandra ^b   Christensen, René D ^c   Ortoft, Gitte ^d   Schledermann, Doris E ^b   Mogensen, Ole ^b  

^a Rigshospitalet   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Endometrial cancer; endometrium; follow up; histopathology; survival; tumor

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL CARCINOMA; DISEASE SPECIFIC SURVIVAL; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFERENCE DATABASE; SALPINGOOOPHORECTOMY; TERTIARY HEALTH CARE; UNDIFFERENTIATED CARCINOMA;

EID: 84863944528     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2012.01438.x     Document Type: Article

References (34)

1. Engholm GSH,. NORDCAN: Cancer Incidences and Mortalities in the Nordic Countries. Association of Nordic Cancer Registries, Danish Cancer Registry, 2007. Available at:. (Accessed 12 May 2012).
2. The North American Association of Central Cancer Registries. Available online at:. (Accessed 12 May 2012).
3. Klint Å,. Cancer i siffror 2009 [Cancer Statistics] (In Swedish). Socialstyrelsen and Cancerfonden: Stockholm, Sweden, 2009. pp. 36-7.
4. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ,. Cancer statistics, 2007. CA Cancer J Clin. 2007; 57: 43-66. (Pubitemid 46148091)
5. Finnish Cancer Registry. Newest survival rates. Available online at:. (Accessed 12 May 2012).
6. Bray F,. Cancer in Norway 2008. Cancer Registry of Norway: Oslo, Norway, 2008. Available at:. (Accessed 12 May 2012).
7. Clemmensen IH,. Kræft i Danmark. En opslagsbog [Cancer in Denmark] (In Danish). In: FADL's Forlag: Copenhagen, Denmark, 2006. pp. 54-5. Available at:. (Accessed 12 May 2012).
8. Straughn JM Jr, Huh WK, Kelly FJ, Leath CA 3rd, Kleinberg MJ, Hyde J Jr, et al,. Conservative management of stage I endometrial carcinoma after surgical staging. Gynecol Oncol. 2002; 84: 194-200. (Pubitemid 34136768)
9. Orr JW Jr, Holimon JL, Orr PF,. Stage I corpus cancer: is teletherapy necessary? Am J Obstet Gynecol. 1997; 176: 777-88.
10. Mazzon I, Corrado G, Morricone D, Scambia G,. Reproductive preservation for treatment of stage IA endometrial cancer in a young woman: hysteroscopic resection. Int J Gynecol Cancer. 2005; 15: 974-8. (Pubitemid 41783111)
11. Eltabbakh GH, Piver MS, Hempling RE, Shin KH,. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial. Int J Radiat Oncol Biol Phys. 1997; 38: 373-80. (Pubitemid 27318655)
12. Yamazawa K, Hirai M, Fujito A, Nishi H, Terauchi F, Ishikura H, et al,. Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer. Hum Reprod. 2007; 22: 1953-8. (Pubitemid 47062765)
13. Hamilton CA, Cheung MK, Osann K, Chen L, Teng NN, Longacre TA, et al,. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer. 2006; 94: 642-6. (Pubitemid 43361894)
14. Farrell R, Scurry J, Otton G, Hacker NF,. Clinicopathologic review of malignant polyps in stage 1A carcinoma of the endometrium. Gynecol Oncol. 2005; 98: 254-62. (Pubitemid 41019114)
15. Kelly MG, O'Malley DM, Hui P, McAlpine J, Yu H, Rutherford TJ, et al,. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol. 2005; 98: 353-9. (Pubitemid 41169144)
16. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I,. Endometrial cancer. Lancet. 2005; 366: 491-505. (Pubitemid 41111699)
17. Chan JK, Kapp DS, Cheung MK, Shin JY, Stieglitz D, Husain A, et al,. Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer. Am J Obstet Gynecol. 2008; 198: 216-5.
18. Fung-Kee-Fung M, Dodge J, Elit L, Lukka H, Chambers A, Oliver T,. Follow-up after primary therapy for endometrial cancer: a systematic review. Gynecol Oncol. 2006; 101: 520-9. (Pubitemid 43729963)
19. Gadducci A, Cosio S, Fanucchi A, Cristofani R, Genazzani AR,. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer. Anticancer Res. 2000; 20: 1977-84. (Pubitemid 30636168)
20. Poulsen HK, Jacobsen M, Bertelsen K, Andersen JE, Ahrons S, Bock JE, et al,. Patienter med tidlige stadier af endometriecancer bør skÃ¥nes for adjuverende strÃ¥lebehandling [Patients with early stages of endometrial cancer should be spared adjuvant radiotherapy. Danish Endometrial Cancer Group]. (In Danish) Ugeskr Laeger 1997; 159: 3403-7.
21. Hogberg T, Fredstorp-Lidebring M, Alm P, Baldetorp B, Larsson G, Ottosen C, et al,. A prospective population-based management program including primary surgery and postoperative risk assessment by means of DNA ploidy and histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with FIGO stage I-II endometrial cancer. Int J Gynecol Cancer. 2004; 14: 437-50. (Pubitemid 38747423)
22. Creasman WT, Kohler MF, Odicino F, Maisonneuve P, Boyle P,. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium. Gynecol Oncol. 2004; 95: 593-6. (Pubitemid 39610410)
23. Bristow RE, Purinton SC, Santillan A, Diaz-Montes TP, Gardner GJ, Giuntoli RL 2nd,. Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance. Gynecol Oncol. 2006; 103: 709-13. (Pubitemid 44602192)
24. Shumsky AG, Stuart GC, Brasher PM, Nation JG, Robertson DI, Sangkarat S,. An evaluation of routine follow-up of patients treated for endometrial carcinoma. Gynecol Oncol. 1994; 55: 229-33.
25. Ng TY, Ngan HY, Cheng DK, Wong LC,. Vaginal vault cytology in the routine follow-up of patients treated for endometrial carcinoma: is it useful? Aust N Z J Obstet Gynaecol. 1997; 37: 104-6. (Pubitemid 27091151)
26. Reddoch JM, Burke TW, Morris M, Tornos C, Levenback C, Gershenson DM,. Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme. Gynecol Oncol. 1995; 59: 221-5.
27. Salvesen HB, Akslen LA, Iversen T, Iversen OE,. Recurrence of endometrial carcinoma and the value of routine follow up. Br J Obstet Gynaecol. 1997; 104: 1302-7. (Pubitemid 27485500)
28. Berchuck A, Anspach C, Evans AC, Soper JT, Rodriguez GC, Dodge R, et al,. Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma. Gynecol Oncol. 1995; 59: 20-4.
29. Sartori E, Pasinetti B, Chiudinelli F, Gadducci A, Landoni F, Maggino T, et al,. Surveillance procedures for patients treated for endometrial cancer: a review of the literature. Int J Gynecol Cancer. 2010; 20: 985-92.
30. Morice P, Levy-Piedbois C, Ajaj S, Pautier P, Haie-Meder C, Lhomme C, et al,. Value and cost evaluation of routine follow-up for patients with clinical stage I/II endometrial cancer. Eur J Cancer. 2001; 37: 985-90. (Pubitemid 32397683)
31. Agboola OO, Grunfeld E, Coyle D, Perry GA,. Costs and benefits of routine follow-up after curative treatment for endometrial cancer. CMAJ. 1997; 157: 879-86. (Pubitemid 27460103)
32. Owen P, Duncan ID,. Is there any value in the long term follow up of women treated for endometrial cancer? Br J Obstet Gynaecol. 1996; 103: 710-3. (Pubitemid 26226152)
33. Sartori E, Pasinetti B, Carrara L, Gambino A, Odicino F, Pecorelli S,. Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients. Gynecol Oncol. 2007; 107: S241-7. (Pubitemid 47483865)
34. Lajer H, Jensen MB, Kilsmark J, Albaek J, Svane D, Mirza MR, et al,. The value of gynecologic cancer follow-up: evidence-based ignorance? Int J Gynecol Cancer. 2010; 20: 1307-20.